Post-laparoscopic mesh in post-menopausal umbilical hernia repair: a case series.
Standard
Post-laparoscopic mesh in post-menopausal umbilical hernia repair: a case series. / Tinelli, Andrea; Malvasi, Antonio; Manca, Corrado; Alemanno, Giovanni; Bettocchi, Stefano; Benhidjeb, Tahar.
In: MINIM INVASIV THER, Vol. 20, No. 5, 5, 2011, p. 290-295.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
Harvard
APA
Vancouver
Bibtex
}
RIS
TY - JOUR
T1 - Post-laparoscopic mesh in post-menopausal umbilical hernia repair: a case series.
AU - Tinelli, Andrea
AU - Malvasi, Antonio
AU - Manca, Corrado
AU - Alemanno, Giovanni
AU - Bettocchi, Stefano
AU - Benhidjeb, Tahar
PY - 2011
Y1 - 2011
N2 - We evaluated the efficacy and safety of the use of a composite PTFE/polypropylene patch, Ventralex (Davol Inc., C.R. Bard, Inc., RI, USA), to repair, concurrent with laparoscopy, umbilical hernia in 51 postmenopausal women. After laparoscopy, patients were submitted to the hernia repair by a patch intraperitoneally placed behind the hernia. Primary outcomes included complication rates, while hernia recurrence was the secondary outcome. Patient age range was 58 ± 4.3 years, the size of patches was small in 17.6% of women, medium in 68.7% and large in 13.7%. Seventy-six percent of patients had an ASA I-II score, the mean operating time for hernia repair was 7 ± 2 minutes with 15 cc of related blood loss, with 1.8 days of hospital stay. The visual analogue scale was 0-3 for 62.7%, 4-6 for 27.5% and 7-10 for 9.8% of women. All laparoscopic and umbilical hernia repair terminated without any further intra or postoperative complications, with 36 months of follow-up; none of the patients showed recurrences. Combining laparoscopy and intraperitoneal mesh repair appears to be indicated for umbilical hernia treatment in post-menopausal patients undergoing laparoscopy, resulting in a safe and easy procedure, with short hospital stay and fast dismissal, with no major morbidity or recurrence.
AB - We evaluated the efficacy and safety of the use of a composite PTFE/polypropylene patch, Ventralex (Davol Inc., C.R. Bard, Inc., RI, USA), to repair, concurrent with laparoscopy, umbilical hernia in 51 postmenopausal women. After laparoscopy, patients were submitted to the hernia repair by a patch intraperitoneally placed behind the hernia. Primary outcomes included complication rates, while hernia recurrence was the secondary outcome. Patient age range was 58 ± 4.3 years, the size of patches was small in 17.6% of women, medium in 68.7% and large in 13.7%. Seventy-six percent of patients had an ASA I-II score, the mean operating time for hernia repair was 7 ± 2 minutes with 15 cc of related blood loss, with 1.8 days of hospital stay. The visual analogue scale was 0-3 for 62.7%, 4-6 for 27.5% and 7-10 for 9.8% of women. All laparoscopic and umbilical hernia repair terminated without any further intra or postoperative complications, with 36 months of follow-up; none of the patients showed recurrences. Combining laparoscopy and intraperitoneal mesh repair appears to be indicated for umbilical hernia treatment in post-menopausal patients undergoing laparoscopy, resulting in a safe and easy procedure, with short hospital stay and fast dismissal, with no major morbidity or recurrence.
KW - Humans
KW - Female
KW - Middle Aged
KW - Treatment Outcome
KW - Length of Stay
KW - Follow-Up Studies
KW - Polytetrafluoroethylene
KW - Postoperative Complications/epidemiology
KW - Polypropylenes
KW - Postmenopause
KW - Blood Loss, Surgical
KW - Hernia, Umbilical/surgery
KW - Laparoscopy/adverse effects/methods
KW - Surgical Mesh/adverse effects
KW - Humans
KW - Female
KW - Middle Aged
KW - Treatment Outcome
KW - Length of Stay
KW - Follow-Up Studies
KW - Polytetrafluoroethylene
KW - Postoperative Complications/epidemiology
KW - Polypropylenes
KW - Postmenopause
KW - Blood Loss, Surgical
KW - Hernia, Umbilical/surgery
KW - Laparoscopy/adverse effects/methods
KW - Surgical Mesh/adverse effects
M3 - SCORING: Journal article
VL - 20
SP - 290
EP - 295
JO - MINIM INVASIV THER
JF - MINIM INVASIV THER
SN - 1364-5706
IS - 5
M1 - 5
ER -
